絞り込み

16532

広告

Coexistence of three EGFR mutations in an NSCLC patient: A brief report.

著者 Belardinilli F , Gradilone A , Gelibter A , Zani M , Occhipinti M , Ferraro S , Nicolazzo C , Coppa A , Giannini G
Int J Biol Markers.2018 Jun 01 ; ():1724600818782200.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (9view , 0users)

Full Text Sources

Miscellaneous

The epidermal growth factor receptor (EGFR) represents a molecular target for tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC) patients with a mutation in the EGFR gene. Mutations of the EGFR gene that occur at a single position in NSCLC tissue are found as single, whereas two or more mutations on the same allele are poorly detected and investigated.
PMID: 29945477 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード